Barclays Maintains an 'Equalweight' on Cree (CREE); Raising Estimates
Tweet Send to a FriendGet Alerts CREE Hot Sheet
Price: $60.41 --0%
Rating Summary:
14 Buy, 17 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 14 | New: 28
Rating Summary:
14 Buy, 17 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 14 | New: 28
Trade CREE Now!
Barclays maintains an 'Equalweight' on Cree (NASDAQ: CREE) price target of $27.00.
Analyst, Amir Rozwadowski, said, "After ~5 quarters of gross margin misses vs. guidance, Cree could finally meet its Mar Q gross margin guide of 34-35% (we model 34.2%) and guide to slight growth in June Q (we model 34.6%) on slightly higher utilizations...We tweak our Mar Q estimates to $302M/$0.20 (Street $301M/$0.21), June Q to $306M/$0.24 (Street $324M/$0.28), and CY12 to $1.32B/$1.15 (Street $1.33B/$1.18)."
For an analyst ratings summary and ratings history on Cree click here. For more ratings news on Cree click here.
Shares of Cree closed at $31.55 yesterday, with a 52 week range of $20.25-$44.83.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Amir Rozwadowski, said, "After ~5 quarters of gross margin misses vs. guidance, Cree could finally meet its Mar Q gross margin guide of 34-35% (we model 34.2%) and guide to slight growth in June Q (we model 34.6%) on slightly higher utilizations...We tweak our Mar Q estimates to $302M/$0.20 (Street $301M/$0.21), June Q to $306M/$0.24 (Street $324M/$0.28), and CY12 to $1.32B/$1.15 (Street $1.33B/$1.18)."
For an analyst ratings summary and ratings history on Cree click here. For more ratings news on Cree click here.
Shares of Cree closed at $31.55 yesterday, with a 52 week range of $20.25-$44.83.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Sterne Agee Upgrades Cree (CREE) to Buy
- Notable Analyst Rating Changes 05/22: (BMY) (CREE) (TEX) Upgraded; (IGTE) (CCL) (NCT) Downgraded
- Benchmark Boosts PT on R.R. Donnelley (RRD)
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
BarclaysLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

